3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Neoplasms
94
Breast Neoplasms
84
Lung Neoplasms
51
Prostatic Neoplasms
47
Colorectal Neoplasms
37
Carcinoma, Non-Small-Cell Lung
32
Pancreatic Neoplasms
29
Hematologic Neoplasms
23
Lymphoma
19
Brain Neoplasms
19
Stomach Neoplasms
18
Ovarian Neoplasms
18
Urinary Bladder Neoplasms
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Multiple Myeloma
15
Leukemia, Myeloid, Acute
15
Esophageal Neoplasms
15
Carcinoma, Hepatocellular
15
Melanoma
14
Liver Neoplasms
14
Leukemia
13
Head and Neck Neoplasms
13
Uterine Cervical Neoplasms
12
Lymphoma, Non-Hodgkin
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Disease
12
Carcinoma, Renal Cell
12
Kidney Neoplasms
11
Colonic Neoplasms
11
Glioma
10
Interventions
edoxaban
1
apixaban
1
Rivaroxaban
1
Heparin, Low-Molecular-Weight
1
Dabigatran
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Embolism
×
30 days
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled